Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with. Racemic 0.25% bupivacaine and 50% enantiomeric excess (S75-R25). Chiral LC for Separation of the Enantiomers of Abacavir sulfate. Autores: D. V. Narasimha Rao. Congresos · Ayuda · Registrarse · Universidad de La Rioja. Antwort. Name* (max. 255 Zeichen) Email (gültige Adresse) Betreff* (max. 255 Zeichen) Text*. | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|